Funding Cures. Saving Lives.
There has never been a more hopeful time in history to invest in childhood cancer research.
Childhood Cancer research is poised for revolutionary innovation. New discoveries in genetics, immunotherapy and biochemistry combined with artificial intelligence, advancements in imaging and gene editing technology will drive unprecedented breakthroughs.
Join us in creating a future where we lose no child to brain cancer, where kids have safer, less toxic treatments and where more of them would get better, and fewer would suffer harsh, chronic side effects in and after remission.
Building on a decade of leadership and results, we’re setting forth on a bold quest.
Our goal is ambitious yet clear: to achieve in 5 years what typically takes a decade.
Why? Because these kids don’t have time.
Lose No Child is a bold and urgent $50 million campaign driving progress to transform treatment, advance research, and develop safer, more effective therapies for kids with brain cancer.
We Are Game-Changers
With a distinctive blend of speed and collaboration, we unite over 300 researchers across 42 leading institutions worldwide
to accelerate breakthroughs in pediatric
brain cancer.
We Fund Dream Teams
Our network brings together oncologists, neurologists, radiologists, biologists, surgeons, geneticists, data analysts, statisticians, patient families, and industry partners—all resolutely committed to eradicating pediatric brain cancer.
We’ve spent the last 10 years building a uniquely collaborative global clinical trial platform that gets results.
Fund our quest for breakthroughs, new and safer
treatments and cures today.
A History-Making FDA Drug Approval for the Most Common Brain Tumor in Kids
For the past decade, our relentless pursuit of breakthrough treatments has led to a landmark FDA drug approval—a game-changing advancement in the fight against pediatric brain cancer. This milestone is just the beginning. Explore our 10-year impact report to see how collaboration, innovation, and bold action are transforming the future of treatment for children.
Through dedication and innovation, we aim to redefine the pace of progress in the fight against the deadliest childhood cancers.
This initiative stands as a beacon of hope, aiming to deliver tailor-made solutions that address the unique challenges of pediatric brain cancer.
More Ways to Make an Impact
DONATE NOW
Make an immediate impact by supporting the fight against pediatric brain cancer. Your donation helps fund research, treatments, and breakthroughs.
MORE WAYS TO GIVE
Looking for different ways to support? From in-kind donations to stocks, crypto, corporate partnerships, and more, explore all the ways you can contribute.
GET IN TOUCH
Have questions or want to discuss how you can help? Reach out to us directly—we’d love to hear from you!
How We Allocate Funds
50%
Clinical Trial Development and Implementation
Purpose: To design, launch, expand and manage new clinical trials.
Details: This includes protocol development, strategies to integrate AI in protocol design and execution, patient recruitment, data collection, regulatory compliance, and trial execution. Emphasizes the importance of well-conducted trials that are both robust and nimble in bringing new therapies to children with brain tumors.
30%
Generating Access to Innovative Therapies
Purpose: To ensure that patients have access to cutting-edge treatments as soon as they become available on a global level.
Details: Supports the launch of international clinical trials, including in low- to middle-income countries, to expand treatment access worldwide.
20%
Development of Predictive Biomarkers and Preclinical Rationale
Purpose: To advance research on predictive biomarkers and preclinical models that guide treatment strategies for pediatric brain tumors.
Details: Focuses on identifying biomarkers that predict treatment response, optimizing early-stage research, and integrating AI-driven approaches to accelerate new therapy development.
FDA Approves Tovorafenib (Day101)
A milestone for children with pediatric low-grade Glioma.
Collaboration, Speed and Hope
Kids with brain cancer don’t have time for business as usual. Neither do we.
“Every year, pediatric brain cancer steals almost 50,000 years of human life in the United States alone. Behind these statistics are countless young lives waiting, hoping, and fighting against a ticking clock. These kids don’t have time for business as usual.”
“Only 5% of cancer drugs are approved first for kids, with many standard treatments last updated more than 30 years ago. Adult trials take over 6 years to trickle down to children.”
Dr Sabine Mueller MD, PhD, MAS
Pediatric neurologist Pediatric
neuro-oncologist
UCSF, PNOC Consortium
Co-Founder
5000
Children are diagnosed
with brain cancer each year.
1%
Pediatric brain cancer
only receives 1% of
federal research funding.
#1
Pediatric brain cancer
is the leading cause of cancer
deaths amongst children.
Hope. Innovation. Action.
We are breaking barriers, transforming treatments, and giving children with brain cancer a future. But we can’t do it alone.
With your support, our doctors, researchers, and specialists can push the boundaries of what’s possible—faster, smarter, and with greater impact.
Join us. Be part of the cure.
The Game Changers
The WORLD-LEADING experts
that benefit from Funding.
SEE LIST
Therapy is on the Way
Read about this
EXCITING NEW DRUG
of hope.
READ MORE
Eleanor Parks
Harvard Research leader
publishes latest study findings.
READ MORE
Ellie’s Journey of Hope
Our NEW FDA APPROVED
THERAPY at work.
ABOUT ELLIE